PF-04191834 Single Dose Bronchodilatory Study In Asthma.

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Study to determine the bronchodilatory effects of PF-04191834 compared with zileuton in patients with asthma

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Zileuton

Criteria

Inclusion Criteria:

• Persistent mild/moderate asthma for at least 6 months.

• Reduced lung function

• Reversible airway obstruction

Exclusion Criteria:

• Pregnant/nursing females.

• Liver function tests greater than upper limit of normal (ULN)